How Much Does Tesamorelin Cost per Month?

Brand-name tesamorelin (Egrifta WR) has a cash price of about $11,030 per kit on Drugs.com's Egrifta WR price guide. Online clinics sell compounded tesamorelin for about $179 to $275 a month. The cheaper plans list doses well below the 2 mg a day used in the belly-fat trials. In those trials, deep belly fat dropped over six months and came back quickly when people stopped. So the number to budget is the monthly price times the months you plan to stay on it.

How much is brand-name tesamorelin without insurance?

Drugs.com lists the cash price of an Egrifta WR 11.6 mg kit at about $11,030 (from $11,029.87). A pack of 30 vials of the 2 mg powder is listed at the same price. These cash prices don't apply if you pay through insurance. Drugs.com doesn't say how many days a kit lasts, so treat $11,030 as a per-kit price, not a monthly one.

The maker runs a co-pay program, the Egrifta WR THERA Co-Pay Assistance Program, which can lower out-of-pocket costs for eligible patients with commercial insurance. Drugs.com found no patient assistance program for people without insurance.

The FDA label covers one use: reducing excess belly fat in adults with HIV who have lipodystrophy (an abnormal shift in where the body stores fat). The label says it is not for weight loss.

With a price that high and a label that narrow, the other option to price is compounded tesamorelin.

How much does compounded tesamorelin cost per month?

Both compounded plans supply a small fraction of the dose used in the trials. TelaCure's listed vial comes to about a sixth of it. Zepym's starting dose comes to about a fifth. TelaCure says its tesamorelin is prepared by a 503A/503B compounding pharmacy and that the prescriber adjusts the dose. Zepym says its pharmacy carries 2 mg/mL and 3 mg/mL strengths, and its price is a "starting at" figure.

Compounded tesamorelin is not the FDA-approved brand-name product. Zepym's own disclosure says the FDA has not reviewed or approved compounded products for safety, effectiveness or quality.

Is a cheaper, lower dose of tesamorelin worth it?

It's a fair question when you're weighing price against dose. One poster in r/Peptides put it this way: "is it worth taking less than 1mg? would 300-600mcg be worthless? is it better to stick with sermorelin for price and dosage?"

The belly-fat results people quote come from 2 mg a day. A plan that costs less because it sends less medicine isn't the same deal at a lower price. It's a different, smaller dose.

Before you pay, ask your clinical team three things:

1. What dose does the monthly price assume?
2. How does that dose compare with the 2 mg a day that was studied?
3. What will it cost if your dose goes up?

How many months of tesamorelin would you have to pay for?

Plan on at least six months. When researchers pooled the trials, studies lasting 26 weeks or longer showed a clear drop in deep belly fat. Shorter studies showed no significant change.

In a 12-month trial, deep belly fat fell about 11% at six months, compared with less than 1% on placebo. People who stayed on for a full year lost about 18%. People who switched to placebo after six months lost those gains quickly. So the cost keeps running for as long as you want to keep the result.

Here's the math with the listed prices:

• At $179 a month, six months is about $1,074 and a year is about $2,148.
• At $275 a month, six months is about $1,650 and a year is about $3,300.

Those totals come before any dose increase or lab work.

Budget for blood sugar checks too. Growth hormone can make it harder for some people's bodies to handle sugar, so researchers advise checking glucose periodically in anyone taking tesamorelin long term.

What does tesamorelin do for your belly, and what doesn't it do?

Tesamorelin targets visceral fat, the deep fat packed around your organs. In a pooled analysis of five trials, it trimmed waist size by about 1.6 cm and added about 1.4 kg of lean mass. It did not lower the fat you can pinch under your skin, and it did not lower BMI. If your goal is a smaller number on the scale, this isn't the drug that moves it.

The big trials enrolled mostly men with HIV. Study 1 had 412 patients with an average age of 48, and 86% were men. Study 2 had 404 patients, and 84% were men. That tells you less about a woman in her 40s who doesn't have HIV.

In the trials behind the label, people on tesamorelin were more likely to develop diabetes than people on placebo (5% vs 1%). The label says not to use it if you are pregnant or planning a pregnancy, have active cancer, have had a pituitary tumor, pituitary surgery or other pituitary problems, or have problems with blood sugar or diabetes.

Side effects reported in the trials include joint aches, muscle aches, tingling and redness where you inject. Ask your clinical team what to watch for.

If what you want is a flatter belly and jeans that fit again, take the quiz. Our clinical team reviews your goal and history to see which plan fits you. That includes GLP-1 options such as semaglutide and tirzepatide, or sermorelin if it suits your goal.